Recently, a real-time follower here on Seeking Alpha asked me to research and post my thoughts around a small, early stage gene therapy concern. Recently, coverage was resumed at Stifel with a $20 price target based on “great promise” showed by the company’s lead drug candidate in Parkinson’s.candidate disease lead patient quarter Recently stage time VY years
Jim Cramer loves when historical patterns pop up in the stock market, especially ones like the recent concerns about FANG stocks being overvalued and emblematic of the 2000 tech bubble.
While Cramer found the piece to be very rational, not all analysts agreed.astray Cramer Facebook found investors lead stock tech Times traded
It’s no secret that market volatility has been trending downward significantly. The fund, which has a Morningstar Analyst Rating of Bronze, also has no basic materials, real estate, telecom, energy, or utilities stocks because they typically sport high debt loads, and the fund can’t hold stocks with a debt/market-cap ratio greater than 30%.fund growth lead manager Morningstar portfolio rating stock versus volatility
Residents in Pittsburgh were given “misleading” statements by health officials who “deflected” attention from lead-contaminated water, according to an audit in a report from the Guardian newspaper.
Pittsburgh discovered lead contamination in residents’ water almost a year ago, after the water utility switched chemicals it used to control metal corrosion.city drinking Flint Guardian lead officials Pittsburgh report residents water
Note: This appears to be a leading indicator for industrial production.
The Chemical Activity Barometer (CAB), a leading economic indicator created by the American Chemistry Council (ACC), ticked up 0.1 percent in July following a flat reading in June and a 0.2 percent gain in May.CAB chemical gain indicator industrial production lead leading month over year
BioLineRx (BLRX) is a $90 million market cap clinical-stage company, focused on immunology and oncology.
BioLineRx BL-8040 lead candidate in oncology is a best-in-class CXCR4 antagonist with a robust clinical program in immuno-oncology.bl cancer candidate clinical CSF lead patient Phase study tumor
Six countries lead our list of best performing ETFs in this week’s ETF Trends Report, most notably Brazil, Turkey, and South Africa, who are all up more than 7%. Banks, Telecoms, and Financials are among the worst performing ETFs this week.Bespoke Brazil countries ETF lead Notably performing Premium report Trend
The takeover of Shriram City Union Finance by IDFC Bank may lead to a change in the structure of how the Chennaibased non-banking finance company is organised, as an effort to reduce costs could lead to some branches and staff of it not becoming part of IDFC Bank, two people familiar with the discussions said.The merged IDFC Bank may not be able to absorb the entire 26,173 employees and about 1,000 branches of Shriram City spread across 22 states, they said, speaking on the condition of anonymity. IDFC Bank employed 3,906 people as of March 31, 2017.Some branches of Shriram City could be parked in a different company that could become a 'business correspondent' for the merged entity, the people said.bank banking branches city correspondent Finance IDFC lead merged Shriram
Omeros Corporation (OMER) is a biopharmaceutical company which develops and commercialize both small-molecule and protein therapeutics for the treatment of inflammation, coagulopathies and disorders of the central nervous system. Omeros has one of the most diverse pipelines and recently emerged as a strong investment target.candidate clinical drug lead Omeros Omidria OMS721 pipeline product stage
One company which definitely has made a statement with respect to embracing change in retail is definitely Wal-Mart (NYSE:WMT). It probably is the one company due to its scale and footprint of stores that can really put it up to the likes of Amazon (NASDAQ:AMZN).acquisition Amazon CEO lead Lore past product scale stock Wal Mart